Celeste Santoro, Research Collaborator at The Netherlands Cancer Institute, shared on LinkedIn:
“On November 11th, I officially completed my residency in Medical Oncology.
I had the opportunity to conclude this journey with a thesis on a subgroup analysis of patients with BRAF-mutant melanoma from the NADINA trial, under the supervision of Prof. Christian Blank and Prof. Giuseppe Curigliano, to whom I am sincerely grateful for their guidance and the opportunities for personal and professional growth.
My heartfelt thanks also go to all my Italian colleagues, the Blank group, and everyone who made this journey so special.
And above all, to the patients, who remind me every day why I chose this path.”
You can also read: ESMO 2026: What’s New in Melanoma Immunotherapy?
